MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
Mr. Gupta is a qualified Chartered Accountant.
With immediate effect
In view of the above, the paid-up equity share capital of the Company has increased from Rs55,40,77,515/- (11,08,15,503 equity shares o
Wockhardt surged 9.51% to Rs 320.05 after the company and Serum Life Sciences UK announced collaboration for manufacturing multiple vac
Wockhardt announced a collaboration with Serum Life Sciences UK Ltd, a subsidiary of the Serum Institute of India, to deliver a global
This trial shall be carried on at NIAIDs Phase I clinical trial units in the USA.
Wockhardt receives support of NIAID for Phase 1 clinical trial of its once-a-day MDR Gram-negative antibiotic WCK 6777
Wockhardt rose 2.15% to Rs 295 after US-based National Institutes of Health (NIH) said it will conduct human phase 1 trial of the drug
The company is making this issue to meet its financing needs for payment of subordinated debt and other objectives.
On 3 March 2022
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
